Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

from Most popular articles from Medical Marketing and Media https://ift.tt/2L5hBpS